|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-5-16
|
|
pubmed:abstractText |
Recent experimental evidence has shown a potential role of interleukin (IL)-11 and its receptor in breast cancer development and progression. However, there is little clinical information to support this hypothesis. We examined the expression of IL-11 and its receptor in primary breast cancer tissue samples and correlated their level of expression with the clinical outcome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1068-9265
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
802-8
|
|
pubmed:dateRevised |
2007-7-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16614887-Breast Neoplasms,
pubmed-meshheading:16614887-Case-Control Studies,
pubmed-meshheading:16614887-Female,
pubmed-meshheading:16614887-Frozen Sections,
pubmed-meshheading:16614887-Humans,
pubmed-meshheading:16614887-Immunoenzyme Techniques,
pubmed-meshheading:16614887-Interleukin-11,
pubmed-meshheading:16614887-Interleukin-11 Receptor alpha Subunit,
pubmed-meshheading:16614887-Neoplasm Recurrence, Local,
pubmed-meshheading:16614887-Prognosis,
pubmed-meshheading:16614887-RNA, Messenger,
pubmed-meshheading:16614887-Receptors, Interleukin,
pubmed-meshheading:16614887-Receptors, Interleukin-11,
pubmed-meshheading:16614887-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16614887-Survival Rate
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer.
|
|
pubmed:affiliation |
University Department of Surgery, Wales College of Medicine, Cardiff University, Heath Park, Cardiff, CF4 4XN, United Kingdom. satheeshh@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
